Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noora Andersson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Plos One|May 1, 2019
BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomasAtte A Manninen, Maria Gardberg, Susanna Juteau, et al.
Cancer Medicine|April 2, 2014
HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up studyAnniina Färkkilä, Noora Andersson, Ralf Bützow, et al.
Journal of Molecular Endocrinology|January 28, 2014
Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibitionNoora Andersson, Mikko Anttonen, Anniina Färkkilä, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovaryStacey Jamieson, Ralf Butzow, Noora Andersson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
Plos One|January 14, 2014
FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cellsMikko Anttonen, Marjut Pihlajoki, Noora Andersson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 4, 2018
Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cellsTea Soini, Katja Eloranta, Marjut Pihlajoki, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2017
Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer CellsElizabeth V Nguyen, Kaisa Huhtinen, Young Ah Goo, et al.
Current Issues in Molecular Biology|June 20, 2022
Analysis of Non-Relapsed and Relapsed Adult Type Granulosa Cell Tumors Suggests Stable Transcriptomes during Tumor ProgressionNoora Andersson, Ulla-Maija Haltia, Anniina Färkkilä, et al.
Human Molecular Genetics|February 4, 2011
Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylaseBérénice A Benayoun, Adrien B Georges, David L'Hôte, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Plos One|May 1, 2019
BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomasAtte A Manninen, Maria Gardberg, Susanna Juteau, et al.
Cancer Medicine|April 2, 2014
HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up studyAnniina Färkkilä, Noora Andersson, Ralf Bützow, et al.
Journal of Molecular Endocrinology|January 28, 2014
Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibitionNoora Andersson, Mikko Anttonen, Anniina Färkkilä, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovaryStacey Jamieson, Ralf Butzow, Noora Andersson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
Plos One|January 14, 2014
FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cellsMikko Anttonen, Marjut Pihlajoki, Noora Andersson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 4, 2018
Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cellsTea Soini, Katja Eloranta, Marjut Pihlajoki, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2017
Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer CellsElizabeth V Nguyen, Kaisa Huhtinen, Young Ah Goo, et al.
Current Issues in Molecular Biology|June 20, 2022
Analysis of Non-Relapsed and Relapsed Adult Type Granulosa Cell Tumors Suggests Stable Transcriptomes during Tumor ProgressionNoora Andersson, Ulla-Maija Haltia, Anniina Färkkilä, et al.
Human Molecular Genetics|February 4, 2011
Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylaseBérénice A Benayoun, Adrien B Georges, David L'Hôte, et al.
Pageof 3